Trial Profile
Neoadjuvant anastrozole in women with endometrial cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2014
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Jan 2014 New trial record